2025年中国创新药License-out大爆发,超10亿美元交易频现!

制药网
Jul 23, 2025

【制药网 行业动态】近期,中国创新药企对外授权巨额交易捷报频传。继翰森制药与再生元达成超20亿美元授权合作、三生制药公布了一项总金额超60亿美元的对外授权BD交易,以及石药集团宣布与阿斯利康订立总金额达53.3亿美元战略研发合作协议后,在日前国内又一家创新药企迎来了License-out交易大单。7月22日,科弈药业宣布,与美国ERIGEN就全球头个并联增强型双靶向CAR-T细胞治疗产品KQ-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10